Astrana Corp (ASTH): Aggregate Business Value

Astrana Corp - graphic logo of issuer ASTH

The localization of clinics within the United States protects Astrana Health, Inc. (ASTH) from external sanctions, although global logistics disruptions are increasing the cost of equipment procurement. Business development relies on expanding the base of medical professionals and insured individuals while strictly monitoring operating profit. This chart of the price trend for Separate Enterprise Value, which stands at 2178.00, confirms margin growth driven by the implementation of IT systems to optimize treatment costs.

ASTH astranahealth.com Real Price to Acquire Entire Company (11/23/2025 - 10/28/2026)
Original product of Apollo Medical Holdings

The complexity of integrating the Value-Based Care platform into CMS systems creates high infrastructure costs for Astrana Health, Inc. (ASTH). This EV chart reflects this specificity, summing market capitalization with net debt to determine the total business buyout price. This metric excludes the impact of cash reserves, exposing the actual costs of asset acquisition. Analyzing the price action allows for an assessment of the model's resilience against technological competitors. The current trend captures the market consensus regarding the cost of this barrier.

Competitors of Astrana Health, Inc.

HCA - Company Buyout Price|Real Price to Acquire Entire Company Tenet THC|FMS - Aggregate Business Value|Enterprise Value Solventum Corporation SOLV|Value Adjusted for Debt and Cash encompasshealth.com|Universal Health Services Inc (UHS) - Real Price to Acquire Entire Company|Aggregate Business Value DVA|RadNet Corp (RDNT) - Total Company Value|Value Adjusted for Debt and Cash Option Care Corp (OPCH)|SGRY: Enterprise Value|Total Enterprise Value premierinc.com PINC|National Vision - Enterprise Value|Progyny Inc (PGNY) - Enterprise Value|ARDT - Real Price to Acquire Entire Company|SEM (Select Medical Inc.) - Aggregate Business Value|Total Company Value MD|Real Price to Acquire Entire Company US Physical Therapy Inc|The Pennant Group - Enterprise Value|Total Enterprise Value ORGO (Organogenesis Holdings Inc.)|NUTX - Total Company Value|AUNA - Business Value|Real Price to Acquire Entire Company SBC Medical Group Holdings Inc. SBC|EOLS - Aggregate Business Value|CYH: Enterprise Value|SKIN (BeautyHealth) - Enterprise Value|MDWD: Total Company Value|Company Buyout Price Biote Corporation (BTMD)|Real Price to Acquire Entire Company The Joint Corp.|Aggregate Business Value DCGO (docgo.com)|Total Company Value P3 Health Partners|Value Adjusted for Debt and Cash gaintherapeutics.com GANX|EUDA Health Holdings Limited - Enterprise Value|BMGL: Enterprise Value|Total Company Value collplant.com|cuprina.com.sg (CUPR) - Business Value|CCM (Concord Medical) - Enterprise Value|Enterprise Value American Shared Hospital Services Inc (AMS)|MEDIROM Healthcare Group Inc (MRM) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash avalon-globocare.com (ALBT)|Enterprise Value DIH Holding US, Inc.|Value Adjusted for Debt and Cash carmellcosmetics.com XAGE|NIVF (NewGenIvf) - Enterprise Value|ATIP - Total Enterprise Value|CMAX: Enterprise Value|KDLY (Kindly Health) - Enterprise Value|Total Company Value ModivCare Inc.|Total Company Value novointegrated.com (NVOS)|Real Price to Acquire Entire Company SunLink Health Systems|Aggregate Business Value IMAC Holdings Inc (BACK)